January 2018 FDA Recall Drug by Pd-rx Pharmaceuticals, Inc.
D-0341-2018 - CGMP deviations.

This Class II drug recall was voluntarily initiated by Pd-rx Pharmaceuticals, Inc. on January 25, 2018 for the product Drug. The FDA reported the reason for recall as cgmp deviations.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0341-2018

Reason for Recall
CGMP deviations.
Initiated
01-25-2018
Reported
02-07-2018
Quantity
7174 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
PD-Rx Pharmaceuticals, Inc.
PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60

Batch or Lot Expiration Information

Lot# Lots: K16E92 Exp. 5/31/18; B17A87 Exp. 5/31/18; E17A51 Exp. 5/31/18; L16B59 Exp. 1/31/18; K16E01 Exp. 5/31/18; A17F21 Exp. 5/31/18; B17D71 Exp. 5/31/18; D17E92 Exp. 5/31/18; J16D13 Exp. 1/31/18; A17D63 Exp. 5/31/18; E17A18 Exp. 5/31/18; F17B87 Exp. 5/31/18; C17C58 Exp. 5/31/18